WorkBoat Header Background Image

WorkBoat+ Membership – Free to Join

Now Available: The U.S. Dredge Report—download today for expert insights, data, and a clear view of the U.S. dredging market.→ Click Here

Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bavarian Nordic R/I ADR (OP:BVNRY)

10.02 -0.01 (-0.10%)
Streaming Delayed Price Updated: 2:42 PM EDT, Apr 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,109
Open 10.01
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 10.03
Today's Range 10.01 - 10.06
52wk Range 7.310 - 13.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat ↗
The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF. 
Via Benzinga

Performance

YTD
-0.1%
-0.1%
1 Month
+3.8%
+3.8%
3 Month
-1.5%
-1.5%
6 Month
-19.6%
-19.6%
1 Year
+33.1%
+33.1%

More News

Read More
News headline image
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows ↗
Via Benzinga
News headline image
UPDATE - International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic ↗
Via Benzinga
News headline image
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped' ↗
Via Benzinga
News headline image
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain ↗
Via Benzinga
News headline image
GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?
Via MarketBeat
News headline image
3 Promising Vaccine Stocks To Watch In The Event Of A Mpox Surge ↗
Via Talk Markets
News headline image
Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening ↗
Via Benzinga
News headline image
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency ↗
Via Benzinga
News headline image
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On? ↗
Via Benzinga
News headline image
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak ↗
Via Benzinga
News headline image
Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data ↗
Via Benzinga
News headline image
Deutsche Bank ADR Investor Conference: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 16th and 17th, 2023
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 16th and 17th, 2023
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines ↗
Via Benzinga
News headline image
Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million
From Emergent BioSolutions
Via GlobeNewswire
News headline image
West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies ↗
Via Benzinga
News headline image
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa ↗
Via Benzinga
News headline image
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗
Via Benzinga
News headline image
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed ↗
Via Benzinga
News headline image
SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report ↗
Via Benzinga

Frequently Asked Questions

Is Bavarian Nordic R/I ADR publicly traded?
Yes, Bavarian Nordic R/I ADR is publicly traded.
What exchange does Bavarian Nordic R/I ADR trade on?
Bavarian Nordic R/I ADR trades on the OTC Traded
What is the ticker symbol for Bavarian Nordic R/I ADR?
The ticker symbol for Bavarian Nordic R/I ADR is BVNRY on the OTC Traded
What is the current price of Bavarian Nordic R/I ADR?
The current price of Bavarian Nordic R/I ADR is 10.02
When was Bavarian Nordic R/I ADR last traded?
The last trade of Bavarian Nordic R/I ADR was at 04/22/26 02:42 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Privacy Policy DSAR Requests Terms of Use Locations Events, Products & Services
© 2026 Diversified Communications. All rights reserved.